Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lukasz S, Ozog"'
Autor:
Esther M. Speer, Elizabet Diago-Navarro, Lukasz S. Ozog, Mahnoor Raheel, Ofer Levy, Bettina C. Fries
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therap
Externí odkaz:
https://doaj.org/article/1d1e849025ad4ae58935abd260aed09f
Autor:
Esther M Speer, David J Dowling, Jianjin Xu, Lukasz S Ozog, Jaime A Mathew, Avinash Chander, Donglei Yin, Ofer Levy
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196352 (2018)
Neonatal inflammation, mediated in part through Toll-like receptor (TLR) and inflammasome signaling, contributes to adverse outcomes including organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which potently suppresses cytokine produc
Externí odkaz:
https://doaj.org/article/84edc266cb8b42bd83c2789ada13676f
Autor:
Ofer Levy, Esther M. Speer, Bettina C Fries, Elizabet Diago-Navarro, Lukasz S. Ozog, Mahnoor Raheel
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef9a4a2e85497182036277a35e22270
https://doi.org/10.3389/fimmu.2020.577878
https://doi.org/10.3389/fimmu.2020.577878
Autor:
Esther M, Speer, Elizabet, Diago-Navarro, Lukasz S, Ozog, Mahnoor, Raheel, Ofer, Levy, Bettina C, Fries
Publikováno v:
Frontiers in Immunology
Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c2bfc8e088d7a4959b71ff0f86692dd
https://pubmed.ncbi.nlm.nih.gov/33072121
https://pubmed.ncbi.nlm.nih.gov/33072121
Autor:
Lukasz S. Ozog, Esther M. Speer, David J. Dowling, Jie Yang, Ofer Levy, Geetika Kennady, Jianjin Xu
Publikováno v:
Pediatric Research. 81:806-816
Toll-like receptor (TLR)-mediated inflammation may contribute to neonatal sepsis, for which pentoxifylline (PTX), a phosphodiesterase inhibitor that raises intracellular cAMP, is a candidate adjunctive therapy. We characterized the anti-inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fb671f6564c3cfdce3971f89a1a0bf
https://doi.org/10.1038/pr.2017.6
https://doi.org/10.1038/pr.2017.6
Autor:
Avinash Chander, Donglei Yin, Esther M. Speer, Jianjin Xu, Ofer Levy, Lukasz S. Ozog, Jaime A. Mathew, David J. Dowling
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0196352 (2018)
PLoS ONE, Vol 13, Iss 5, p e0196352 (2018)
Introduction Neonatal inflammation, mediated in part through Toll-like receptor (TLR) and inflammasome signaling, contributes to adverse outcomes including organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which potently suppresses cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8dba4093e1f681e1b7557d5309da96
http://europepmc.org/articles/PMC5929513
http://europepmc.org/articles/PMC5929513